Skip to content

Study on effect of Ningxin Anshen Fang in treating post-stroke insomnia of type of deficiency of both the heart and spleen

Study on effect of Ningxin Anshen Fang in treating post-stroke insomnia of type of deficiency of both the heart and spleen

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015225
Enrollment
Unknown
Registered
2018-03-15
Start date
2018-03-19
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke insomnia

Interventions

Ningxin Anshen Fang Group:Ningxin Anshen Fang
Placebo Group:Placebo
Zopiclone Group:Zopiclone

Sponsors

East Zone of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The diagnostic criteria of insomnia and type of deficiency of both the heart and spleen of insomnia in TCM; 2. The cerebral infarction: 14 days less than 180 days' duration, NIHSS score less than 8 points, 7 points more than PSQI, and insomnia appeared in type of deficiency of both the heart and spleen of insomnia in TCM; 3. Aged 30 to 85 years old; 4. No taking sedative or stopped more than l weeks; 5. Volunteer to participate in the test, sign the informed consent and adhere to the treatment.

Exclusion criteria

Exclusion criteria: 1. the patients with insomnia caused by systemic diseases such as pain, fever, cough, operation and external environment disturbance; 2. patients with acute severe disease and blood borne diseases such as heart, lung, kidney and liver; 3. combined with schizophrenia and other serious mental disorders; 4. can not complete the treatment; 5. women during pregnancy and lactation; 6. The allergic constitution.

Design outcomes

Primary

MeasureTime frame
PSQI;

Secondary

MeasureTime frame
Syndrome score table;

Countries

China

Contacts

Public ContactXiong Hang

East Zone of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

xionghang2004@sina.com+86 18001263583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026